CBD suppressed colorectal cancer proliferation by signaling through CB1, TRPV1, and PPARγ receptors, and interestingly, antagonists of these receptors effectively reduced CBD’s anti-proliferative properties [27]. Here, CNR1 is linked to colorectal cancer.